GOLDMAN SACHS GROUP INC - ATOSSA THERAPEUTICS INC ownership

ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 73 filers reported holding ATOSSA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ATOSSA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$70,000
-45.3%
64,273
-37.2%
0.00%
Q1 2022$128,000
-69.2%
102,321
-60.6%
0.00%
Q4 2021$416,000
-38.5%
259,856
+25.2%
0.00%
Q3 2021$676,000
+113.9%
207,569
+315.1%
0.00%
Q2 2021$316,000
+134.1%
50,007
-21.6%
0.00%
Q1 2021$135,000
+159.6%
63,770
+199.3%
0.00%
Q3 2020$52,00021,3040.00%
Other shareholders
ATOSSA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 362,072$453,0000.07%
GSA CAPITAL PARTNERS LLP 66,223$83,0000.01%
Aquatic Capital Management LLC 4,400$6,0000.01%
D. E. Shaw & Co., Inc. 3,863,135$4,829,0000.01%
Spire Wealth Management 94,000$118,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 111,898$140,0000.00%
Renaissance Technologies 2,100,492$2,626,0000.00%
ALPS ADVISORS INC 130,141$163,0000.00%
Cutler Group LLC / CA 21,400$30,0000.00%
TWO SIGMA ADVISERS, LP 681,600$852,0000.00%
View complete list of ATOSSA THERAPEUTICS INC shareholders